πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 263 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9198645

Controlled vesicle self-assembly in continuous two phase flow microfluidic channels

The United States of America, as Represented by the Secretary of Commerce National Institute of Standards and Technology Β· Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9114151

Method for modulating or controlling sodium channel current by reactive oxygen species (RO

THE UNITED STATES OF AMERICA DEPT. OF VETERANS AFFAIRS Β· Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9115187

Identification of antibodies specific for lyssaviruses and methods of their use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9101582

Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathoge

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9072792

Peptides whose uptake by cells is controllable

The Regents of the University of California Β· Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9066936

Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9066855

Controlled release auris sensory cell modulator compositions and methods for the treatment

The Regents of the University of California Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9046520

Serologic correlates of protection against Bacillis anthracis infection

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9034323

Method for control of post-prandial glucose

HALOZYME, INC. Β· Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9005649

Methods for making controlled delivery devices having zero order kinetics

The Board of Regents of the University of Texas System Β· Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9000141

Localization and characterization of flavivirus envelope glycoprotein cross-reactive epito

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8980322

Controlled release composition

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8962588

Micro-RNAS that control myosin expression and myofiber identity

The Board of Regents of the University of Texas System Β· Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8946444

Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational cont

PTC THERAPEUTICS, INC. Β· Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8936794

Conducting polymer nanotube actuators for precisely controlled release of medicine and bio

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8883948

Methods for extensive dark curing based on visible-light initiated, controlled radical pol

The Regents of the University of Colorado Β· Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8865461

Rabies virus vector systems and compositions and methods thereof

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8852626

Controlled-release CNS modulating compositions and methods for the treatment of otic disor

The Regents of the University of California Β· Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8846051

Modulation of replicative fitness by deoptimization of synonymous codons

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8846770

Controlled release aural pressure modulator compositions and methods for the treatment of

The Regents of the University of California Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8846056

Anti-RSV immunogens and methods of immunization

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8828980

Controlled release corticosteroid compositions and methods for the treatment of otic disor

The Regents of the University of California Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8828429

Release-control composition

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8815801

Controlled release composition and method of producing the same

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted